South Asia (IDA & IBRD) vs Türkiye: Immunization, HepB3
South Asia (IDA & IBRD)
94.5%
in 2024
Türkiye
99.0%
in 2024
South Asia (IDA & IBRD) rank
1st
Türkiye rank
1st
Immunization, HepB3 over time
- South Asia (IDA & IBRD)
- Türkiye
How they compare
Türkiye currently reports 99.0% against 94.5% in South Asia (IDA & IBRD), a difference of 4.5%.
Across all 25 years both countries report, Türkiye has been ahead every year.
South Asia (IDA & IBRD) ranks 1st and Türkiye ranks 1st of 47 groups.
Türkiye has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Asia (IDA & IBRD) | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.4% | 81.4% | 67.0% | Türkiye |
| 2010s | 77.2% | 97.0% | 19.8% | Türkiye |
| 2020s | 90.6% | 98.2% | 7.6% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, South Asia (IDA & IBRD) or Türkiye?
- Türkiye, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.
- What is the difference in immunization, hepb3 between South Asia (IDA & IBRD) and Türkiye?
- 4.5%, with Türkiye ahead.
- How many years of comparable data are there for South Asia (IDA & IBRD) and Türkiye?
- 25 years are reported by both, from 2000 to 2024.
- How do South Asia (IDA & IBRD) and Türkiye rank globally for immunization, hepb3?
- South Asia (IDA & IBRD) ranks 1st and Türkiye ranks 1st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.